# Novartis Pharmaceuticals Corporation – FDA Inspection, Apr 7, 2017

Source: https://www.keypedia.com/records/fda_inspections/novartis-pharmaceuticals-corporation/9ab30769-64e6-41c7-bcc0-e04710bf5034
Source feed: FDA_Inspections

> FDA inspection 1019194 of Novartis Pharmaceuticals Corporation, April 07, 2017. Form 483 issued. 4 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1019194
- Company Name: Novartis Pharmaceuticals Corporation
- Inspection Date: 2017-04-07
- Product Type: Biologics
- Center: Biologics
- Office Name: New Jersey District Office
- Citation Count: 0

## Related Documents

- [FDA Inspection 1300144 - 2026-02-06](https://www.keypedia.com/records/fda_inspections/novartis-pharmaceuticals-corporation/dda9986d-7403-4915-9abe-66007c22736d)
- [FDA Inspection 1245942 - 2024-08-08](https://www.keypedia.com/records/fda_inspections/novartis-pharmaceuticals-corporation/d2f19248-2be2-424d-85b3-a50251928268)
- FDA Inspection 1194474 - 2022-12-09
- [FDA Inspection 1100101 - 2019-08-21](https://www.keypedia.com/records/fda_inspections/novartis-pharmaceuticals-corporation/e4fab4a0-2d49-44f2-a6c8-f6170fd44cd2)

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/ashley-j-burns/c4344aad-6456-4e9f-b992-09941b734fe6)
- [Investigator](https://www.keypedia.com/people/joan-johnson/5da1159e-453c-49a1-8e6d-5fa6b9fb0352)
- [Company Rep](https://www.keypedia.com/people/randa-melhem/7c1d0c80-f768-487b-83a1-7145b0d0a7f8)

Company: https://www.keypedia.com/companies/novartis-pharmaceuticals-corporation/21559fd5-35ed-4cbd-b228-623dd76bcf47

Office: https://www.keypedia.com/offices/new-jersey-district-office/6ff5e2e9-5cff-44c7-af24-5a55329a8248